Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Federal Hemp Rewrite Could Hit CBD Too
A federal crackdown aimed at intoxicating hemp may also hit many non intoxicating CBD products because of trace THC limits. The bigger lesson is that chemistry details now carry real supply chain and survival risk.
Schedule III Push Survives DOJ Shakeup
The latest reporting says a Justice Department shakeup is not expected to kill the federal push to move cannabis to Schedule III. The real operator question is not just when the rule lands. It is whether lawsuits delay when the tax benefit becomes real.
Texas Smokable Hemp Rules Leave Mail Order Risk Unclear
Texas now blocks in state sales of smokable hemp products, but the bigger issue is what happens next with mail orders and enforcement. Regulators say shipped products must comply too, while attorneys say online orders from out of state still sit in a legal gray area.
White House CBD Meetings Put Federal Compliance Back In Play
The White House has scheduled four meetings on FDA’s pending CBD compliance and enforcement policy. That does not make the rules final, but it is a real federal signal that labels, claims, and distribution risk deserve a fresh review.
Federal CBD Compliance Review Moves Forward
The White House has scheduled an April 1 review of FDA’s proposed CBD compliance and enforcement policy. That does not make the rules final, but it is a real federal signal that labeling, claims, and distribution risk deserve a fresh look.
Michigan Lab Data Integrity Complaints Put COAs Under A Microscope
Michigan filed formal enforcement complaints against a licensed cannabis testing lab, raising data integrity and COA reliability concerns. For operators, this is a reminder to tighten traceability, diversify lab exposure, and stay recall ready.
Colorado Cannabis Recall After Retesting Finds Chlorfenapyr
A Colorado health advisory triggered a voluntary recall after a cannabis concentrate batch that initially passed testing was later found to contain chlorfenapyr above limits. Here is the operator checklist to respond fast and tighten lab risk controls.
California Condemnation Order Shows Why Track And Trace Protects Your License
California issued a final condemnation order requiring destruction of embargoed inventory after inspectors documented missing UID traceability and unsourced materials. The lesson is simple: track and trace is the product.
California Voluntary Vape Recall Highlights Traceability And Misbranding Risk
California issued a voluntary recall for Luigi integrated vaporizers after DCC said the distillate could not be traced to a verified source. The operator lesson is simple: traceability is the product.
Oklahoma Mandatory Recall Shows How Lab Errors Become Supply Chain Risk
Oklahoma issued a mandatory recall tied to unreliable yeast and mold testing results from a licensed lab. Here is the operator playbook to audit by batch number, quarantine fast, and stay inspection ready.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.